Insider Transactions in Q4 2024 at Ultragenyx Pharmaceutical Inc. (RARE)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 10
2024
|
Howard Horn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,465
-7.48%
|
$388,180
$52.76 P/Share
|